Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 50 of 272 entries
View as:

Eziclen Drug Utilisation in Real Life Setting

Phase: N/A Priority: Normal
NCT ID: NCT02630680 Org: User:
Start: 10/31/15 End: 04/25/17 Due: 04/25/18

Treatment of Children and Adolescents With Growth Failure Associated With Primary IGF-1 Deficiency

Phase: N/A Priority: Normal
NCT ID: NCT00330668 Org: User:
Start: 11/30/05 End: 03/31/10 Due: 03/31/11

To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence.

Phase: N/A Priority: Normal
NCT ID: NCT00255372 Org: User:
Start: 04/30/05 End: 05/20/08 Due: 05/20/09

EGb 761® (Tanakan®) Effectiveness in the Treatment of Patients of Middle Age and Younger With Psycho-emotional Symptoms, Added to Cognitive Disorders

Phase: N/A Priority: Normal
NCT ID: NCT02321475 Org: User:
Start: 06/30/14 End: 04/30/15 Due: 04/30/16

A Study to Review Treatment Outcomes From Treatment With Dysport® Injections in Adults for Upper and/or Lower Limb Focal Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT04604379 Org: User:
Start: 02/04/21 End: 05/28/21 Due: 05/28/22

Effectiveness of Smecta in the Treatment of Acute Diarrhoea in Children

Phase: N/A Priority: Normal
NCT ID: NCT00352716 Org: User:
Start: 06/30/06 End: 02/01/07 Due: 02/01/08

ETREAT Study on Effectiveness of Botulinum Toxin Type A Injections to Treat Post-stroke Upper and/or Lower Limb Spasticity

Phase: N/A Priority: Normal
NCT ID: NCT02275312 Org: User:
Start: 07/31/14 End: 07/31/17 Due: 07/31/18

Quality of Life, Treatment Experience and Cost of Treatment With Somatostatin Analogues in Patients With Gastroenteropancreatic Neuroendocrine Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02788565 Org: User:
Start: 03/31/16 End: 12/31/16 Due: 12/31/17

Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR

Phase: N/A Priority: Normal
NCT ID: NCT00216398 Org: User:
Start: 06/30/04 End: 06/22/06 Due: 06/22/07

Non Interventional Post Marketing Programme in Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT00747500 Org: User:
Start: 07/31/08 End: 03/31/13 Due: 03/31/14

Study on the Use of Botulinum Toxin Type A in the Treatment of Chronic Post-stroke Spastic Patients

Phase: N/A Priority: Normal
NCT ID: NCT02390206 Org: User:
Start: 06/30/15 End: 08/28/17 Due: 08/28/18

Randomized, Placebo-Controlled Study of AbobotulinumtoxinA (Dysport®) for the Treatment of Cervical Dystonia

Phase: N/A Priority: Normal
NCT ID: NCT00257660 Org: User:
Start: 10/10/05 End: 09/30/06 Due: 09/30/07

Patient and Physician Survey on Satisfaction With Somatostatin Analogue (SSA) Injections in Acromegaly in China

Phase: N/A Priority: Normal
NCT ID: NCT05184231 Org: User:
Start: 02/13/23 End: 10/31/23 Due: 10/31/24

Validation Study of the SAGIT® Instrument in Acromegaly

Phase: N/A Priority: Normal
NCT ID: NCT02539927 Org: User:
Start: 07/31/15 End: 09/03/18 Due: 09/03/19

Retrospective Real-Life Study From One Brazilian Reference Center Assessing Long-Term Experience In The Treatment Of Adult Spasticity With AbobotulinumtoxinA

Phase: N/A Priority: Normal
NCT ID: NCT04446702 Org: User:
Start: 03/05/21 End: 12/10/21 Due: 12/10/22

Dysport® Pediatric Lower Limb Spasticity Follow-on Study

Phase: N/A Priority: Normal
NCT ID: NCT01251380 Org: User:
Start: 10/31/11 End: 01/31/15 Due: 01/31/16

Validation of Patient Reported Outcome Measures for Use in Vulvodynia

Phase: N/A Priority: Normal
NCT ID: NCT03770169 Org: User:
Start: 02/18/19 End: 09/19/19 Due: 09/19/20

BN83495 in Prostate Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00790374 Org: User:
Start: 01/31/09 End: 02/28/11 Due: 02/28/12

Study to Evaluate Patients With Acromegaly Treated With Lanreotide Autogel (Somatuline ATG)

Phase: N/A Priority: Normal
NCT ID: NCT00517491 Org: User:
Start: 05/31/08 End: 12/31/08 Due: 12/31/09

Study of Quality of Life and Hormone Levels in Premenopausal Participants With Early Breast Cancer Receiving Triptorelin Plus Additional Cancer Treatment

Phase: N/A Priority: Normal
NCT ID: NCT05377684 Org: User:
Start: 06/09/22 End: 06/30/26 Due: 06/30/27

Study of Lanreotide Autogel 120 mg in Patients With Non-functioning Entero- Pancreatic Endocrine Tumour

Phase: N/A Priority: Normal
NCT ID: NCT00842348 Org: User:
Start: 02/28/09 End: 12/31/15 Due: 12/31/16

Adult Subjects Suffering From Lower Limb Spasticity Following Stroke

Phase: N/A Priority: Normal
NCT ID: NCT01444794 Org: User:
Start: 09/30/11 End: 02/28/13 Due: 02/28/14

Description of Sign-and-symptom Associations at Acromegaly Diagnosis.

Phase: N/A Priority: Normal
NCT ID: NCT02012127 Org: User:
Start: 09/30/13 End: 06/30/14 Due: 06/30/15

A Retrospective Data Analysis of Therapy With PRRT Combined With Lanreotide Autogel® for Neuroendocrine Tumours

Phase: N/A Priority: Normal
NCT ID: NCT02788578 Org: User:
Start: 06/30/16 End: 07/31/17 Due: 07/31/18

The Effectiveness of Circadin in Improving Quality of Sleep in Patients Aged 55 or Over

Phase: N/A Priority: Normal
NCT ID: NCT02321449 Org: User:
Start: 06/30/14 End: 02/28/15 Due: 02/28/16